Assessment of potential of AgNOR counts as tumor marker in cervical carcinogenesis.
Misra
Jata S
JS
Chhavi
Singh
Madhulika
M
Srivastava
Anand N
AN
Das
Vinita
V
D000941:Antigens / Q000032:analysis*; D034961:Antigens, Nuclear / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009687:Nuclear Proteins / Q000032:analysis*; D009697:Nucleolus Organizer Region / Q000473:pathology*; D011230:Precancerous Conditions / Q000737:chemistry / Q000175:diagnosis* / Q000628:therapy; D011237:Predictive Value of Tests; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000628:therapy; D002578:Uterine Cervical Dysplasia / Q000737:chemistry / Q000175:diagnosis* / Q000628:therapy
D000941:Antigens; D034961:Antigens, Nuclear; D014408:Biomarkers, Tumor; D009687:Nuclear Proteins; C051963:nucleolar organizer region associated proteins